Keyphrases
Ventilator-associated Pneumonia
100%
Treatment Options
40%
Hospital-acquired Infection
20%
United States
20%
Patient Outcomes
20%
Patient Care
20%
Antimicrobial
20%
Treatment Strategy
20%
Impact-based
20%
Health Care Costs
20%
Antimicrobial Therapy
20%
Antimicrobial Resistance
20%
Nosocomial Infection
20%
Microbiological Test
20%
Rapid Diagnostic Test
20%
Empirical Therapy
20%
Increasing Prevalence
20%
Antimicrobial Use
20%
Testing Method
20%
Expert Commentary
20%
Area Cover
20%
Multidrug-resistant Bacteria
20%
Microbial Pathogens
20%
New Antimicrobials
20%
Pneumonia Treatment
20%
National Surveillance Data
20%
Nursing and Health Professions
Ventilator-Associated Pneumonia
100%
Antiinfective Agent
60%
Diagnosis
40%
Hospital Infection
40%
Prevalence
20%
Treatment Outcome
20%
Health Care Cost
20%
Antimicrobial Therapy
20%
Antimicrobial Resistance
20%
Pharmacology, Toxicology and Pharmaceutical Science
Ventilator Associated Pneumonia
100%
Antiinfective Agent
60%
Hospital Infection
40%
Prevalence
20%
Infectious Agent
20%
Antimicrobial Therapy
20%
Antimicrobial Resistance
20%